Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1996 May;19(4):287-9.
doi: 10.1093/sleep/19.4.287.

A double-blind, randomized trial of sabeluzole--a putative glutamate antagonist--in obstructive sleep apnea

J Hedner  1 , R Grunstein, B Eriksson, H Ejnell
Affiliations
Clinical Trial

A double-blind, randomized trial of sabeluzole--a putative glutamate antagonist--in obstructive sleep apnea

J Hedner et al. Sleep. 1996 May.

Abstract

The effect of sabeluzole (SAB), an agent with anti-excitatory amino acid activity, on sleep, breathing and daytime symptoms was investigated in 13 patients with obstructive sleep apnea (OSA). There was marked interindividual variation in both the effect on sleep and breathing and the plasma concentration of SAB. However, individual plasma drug concentration was highly correlated (r = 0.82, p = 0.02) with a reduction of the oxygen desaturation index during sleep (ODI) after treatment with SAB. Further investigation of this and agents of this type are warranted in patients with OSA.

PubMed Disclaimer

Publication types